The largest database of trusted experimental protocols

20 protocols using ac yvad cmk

1

TLR4 Activation and Inflammatory Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells at a density of 2 × 106 cells/mL were treated with 100 ng/mL of the Toll-like receptor 4 (TLR4) ligand E. coli lipopolysaccharide (LPS; Invivogen, San Diego, CA) in the presence or absence of 1 mM SSZ (Sigma-Aldrich, St. Louis, MO), and incubated for 24 h at 37°C in 5% CO2. The concentration of SSZ and the incubation time were selected after evaluation of cellular toxicity, where <1% of PBMC mortality [evaluated by Trypan blue exclusion staining and Fixable Viability Dye eFluor 506 (eBioscience)] was obtained at the chosen condition (n = 5, data not shown). Subsequently, the cells were stimulated with PMA and ionomycin (at 50 and 500 ng/mL, respectively), and incubated for 12 h at 37°C in 5% CO2, all in the presence of 5 μg/mL of Brefeldin A and monensin, previous evaluation of cell viability with the Fixable Viability Dye eFluor 506. Finally, the cells were harvested, followed by surface and intracellular staining, as described above. In a fraction of individuals, PBMC were cultured with LPS plus SSZ in the presence or absence of the caspase-1 inhibitor Ac-YVAD-cmk or the pan-caspase inhibitor Z-VAD-FMK (at 0.25 and 5 μg/mL, respectively; both from InvivoGen), and the type of cell death was evaluated with the TACS Annexin V Kits (Trevigen), following the manufacturer's instructions.
+ Open protocol
+ Expand
2

NLRP3 Inflammasome Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nigericin, LPS from E. coli strain 0111:B4, and BFA were from Sigma-Aldrich. Phorbol 12-myristate 13-acetate (PMA), MSU, ATP, alum, glybenclamide, Ac-YVAD-cmk, MCC950 (kind gift from F. Niedergang) were from Invivogen. Primary polyclonal rabbit anti-FADD (2782), monoclonal rabbit IgG anti-NLRP3 clone D2P5E, monoclonal rabbit IgG anti-CASPASE-1 clone D7F20, polyclonal rabbit anti-CASPASE-4 (4450), monoclonal mouse anti-CASPASE-8 (1C12), and monoclonal rabbit IgG clone E1E3I anti-ASC antibodies were from Cell Signaling Technologies. Monoclonal mouse anti-α-Tubulin clone DM1A and monoclonal ECL horseradish peroxidase-conjugated-linked mouse anti-β-Actin clone AC-15 were from Sigma-Aldrich. Secondary antibodies used for immunoblot, ECL horseradish peroxidase-conjugated-linked donkey antibody (F(ab′)2 fragment) anti-rabbit IgG (NA9340V), and ECL horseradish peroxidase-conjugated-linked goat anti-mouse IgG1 (M32107), were from GE Healthcare and Caltag, respectively.
+ Open protocol
+ Expand
3

Transfection and Inhibition of HIV-1 LTR

Check if the same lab product or an alternative is used in the 5 most similar protocols
We seeded HMG or HFMG at a density of 2.5×105 cells /well in a 48 well plate. At day 6, cells were transfected with GU-rich RNA within the HIV LTR (ssRNA40)/lyovec (Invivogen Cat# tlrl-lrna40) and ssRNA41/lyovec (identical to ssRNA40 with the exception that uridines are replaced with adenosines) (Invivogen Cat# tlrl-lrna41) for 24h and 48h. Both cell supernatants for ELISA and cell lysates for western blot analysis were collected. For inhibitor treatments, caspase-1 inhibitor, Ac-YVAD-cmk (Invivogen Cat# inh-yvad) or Z-WEHD-FMK (R&D Systems Cat# FMK002) or MCC950 (Adipogen Cat# AG-CR1–3615), cells were pre-incubated for 2h at 37°C prior to addition of ssRNA40. In parallel, untreated and ssRNA41 treated cells were also incubated at 37°C.
+ Open protocol
+ Expand
4

BMDM Inflammasome Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A macrophage-based assay was adapted from previously described protocols to assess inflammasome activation in BMDMs [60 (link)]. Frozen BMDMs were thawed and plated in 24-well or 96-well tissue culture-treated, flat-bottom plates in complete DMEM (DMEM + 2mM L-glutamine + 10% FBS + 1% Pen/Strep) at a density of 1x106 or 2x105 cells per well, respectively. After plating, cells were left to rest at 37°C and 5% CO2 overnight. BMDMs were then primed using 1μg/mL Pam3CSK4 (InvivoGen) for 17 hours (h) or left untreated. Primed BMDMs were stimulated with DENV NS1, 5μM nigericin (Invivogen), or left untreated. After 24h, supernatants were spun down at 10,600 x g for 10 minutes, and the cell-free supernatant was collected. BMDM layers were washed twice with PBS and then lysed in RIPA buffer (150mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 50mM Tris pH 7.4) supplemented with protease inhibitor (Roche). Supernatants and cell lysates were stored at -80°C until further analysis. For experiments involving inhibitors, the NLRP3 inhibitor MCC950 (InvivoGen) or caspase-1 inhibitor Ac-YVAD-cmk (InvivoGen) were added at indicated concentrations 30 min prior to treatment with DENV2 NS1 or nigericin.
+ Open protocol
+ Expand
5

Cell Death Inhibitors Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
If not otherwise specified, one of the following cell death inhibitors was added to the cells: (10 μM) 1–2 h prior to cell stimulation with dsDNA: Z-VAD(OMe)-FMK (Cell Signaling), Z-DEVD-FMK (R&D Systems), MCC950 (Invivogen), Nec-1 (Abcam) or Ac-YVAD-cmk (Invivogen).
+ Open protocol
+ Expand
6

NLRP3 Inflammasome Activation in HCASMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cells were kept at 5% CO2 and 37 °C. HCASMCs were treated with isolated NLRP3-YFP inflammasome particles (3:1 NLRP3-YFP particles/ cell) for 4 h (internalization, gene expression, migration, western blot) and 24 h (gene expression, extracellular matrix production). For mechanistic studies, NLRP3 inhibitor MCC950 (1 µM, Invivogen), caspase-1 inhibitor Ac-YVAD-cmk (25 µg/ml, Invivogen) and NFκB inhibitor IKK-16 (2 µM, Selleckchem) were added to the media 30 min before treatment. Endocytosis inhibitor Cytochalasin D (4 µM, Invitrogen) was added 30 min before treatment with NLRP3-YFP particles and was washed off 3 times by washing with culture medium.
+ Open protocol
+ Expand
7

Rat H9C2 Cardiomyocyte Hypoxia-Reoxygenation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat heart-derived H9C2 cells were purchased from ATCC and cultured using DMEM medium (Hyclone, Logan, UT, USA) containing 100 IU/ml of penicillin–streptomycin (Beyotime, Shanghai, China) and 10% fetal bovine serum (Hyclone, Logan, UT, USA) at 37°C in a 5% CO2 incubator. For H/R treatment, H9C2 cells were subjected to 16 h of hypoxia (O2:N2:CO2, 1:94:5) followed by 2 h of reoxygenation. To inhibit the activity of caspase-1, cells were treated with AC-YVAD-CMK (10 μg/ml, InvivoGen, San Diego, CA, USA). To suppress the activity of PI3K, cells were treated with 5 μM GDC-0941 (MedChemExpress, Monmouth Junction, NJ 08852, USA). All experiments were performed in 12-well plates, and cells were seeded at a density of 0.1 × 106 cells/well. Cells were collected for further analysis 24 h after indicated treatments.
+ Open protocol
+ Expand
8

Inflammatory Cytokine Signaling Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Polybrene, TRIzol and Lipofectamine 2000 were obtained from Invitrogen (Carlsbad, CA, USA). PMA (Cat#P8139), ATP (Cat#A7699), LPS (Cat#L2630), U0126 (Cat#U120), and Bay11–7082 (Cat#B5556) were obtained from Sigma-Aldrich (St. Louis, MO, USA). Ac-YVAD-cmk (Cat#inh-yvad) was ordered from InvivoGen (San Diego, CA, USA). PierceTM DSS (Cat#A39267) was ordered from Thermo Scientific (Waltham, MA, USA). IL-1β (human) ELISA Kit II (Cat# 557966) was from BD Biosciences (San Jose, CA, USA). Antibody anti-GAPDH (Cat# 60004-1-lg) was obtained from Proteintech (Wuhan, China). Antibodies anti-NLRP3 (clone ID: D4D8T), IL-1β (clone ID: D3U3E), and Caspase-1 (clone ID: D7F10) were obtained from Cell Signaling Technology (Beverly, MA, USA). Antibodies anti-ASC (clone ID: B-3) and anti-ASC (clone ID: F-9) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
+ Open protocol
+ Expand
9

Inhibiting Caspase-1 Activity in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
To inhibit caspase-1 activity in vivo, mice received Ac-YVAD-cmk (8 mg/kg per time, once weekly for 8 weeks; InvivoGen, San Diego, California) in dimethyl sulfoxide (5% v/v) or dimethyl sulfoxide alone intraperitoneally.
+ Open protocol
+ Expand
10

Fibroblast Viability after Oxidative Stress

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess cell viability of fibroblasts following oxidative stress, human fibroblasts corresponding to the ages of 49 and 52 y/o were grown in culture and exposed to 25 μM hydrogen peroxide for 30 min. Then, the CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega, Madison, WI) was used according to manufacturer’s instructions to evaluate the number of lysed cells as described in [6 (link)]. Another group of cells (52 years-old) was exposed to 25 μM hydrogen peroxide and 10 μg/ml of the caspase-1 inhibitor Ac-YVAD-CMK (Invivogen) prior to LDH release analysis. Ac-YVAD-CMK is a cell permeable, irreversible, selective inhibitor that prevents the cleavage of caspase-1, thus preventing its activation. Studies were replicated 5 times for all groups.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!